AAAAAA
Results: 1-25/51
Authors:
MILLWARD MJ
WEBSTER LK
RISCHIN D
STOKES KH
TONER GC
BISHOP JF
OLVER IN
LINAHAN BM
LINSENMEYER NE
WOODCOCK DM
Citation: Mj. Millward et al., PHASE-I TRIAL OF CREMOPHOR EL WITH BOLUS DOXORUBICIN, Clinical cancer research, 4(10), 1998, pp. 2321-2329
Authors:
BISHOP JF
Citation: Jf. Bishop, APPROACHES TO INDUCTION THERAPY, Leukemia & lymphoma (Print), 30, 1998, pp. 32-33
Authors:
BISHOP JF
MATTHEWS JP
YOUNG GAR
BRADSTOCK K
LOWENTHAL RM
Citation: Jf. Bishop et al., INTENSIFIED INDUCTION CHEMOTHERAPY WITH HIGH-DOSE CYTARABINE AND ETOPOSIDE FOR ACUTE MYELOID-LEUKEMIA - A REVIEW AND UPDATED RESULTS OF THEAUSTRALIAN-LEUKEMIA-STUDY-GROUP, Leukemia & lymphoma, 28(3-4), 1998, pp. 315-327
Authors:
OLVER IN
GREEN M
MILLWARD MJ
BISHOP JF
Citation: In. Olver et al., PHASE-II STUDY OF ACIVICIN IN PATIENTS WITH RECURRENT HIGH-GRADE ASTROCYTOMA, Journal of clinical neuroscience, 5(1), 1998, pp. 46-48
Authors:
RIVORY LP
CLARKE S
BISHOP JF
ODONNELL A
EMMETT L
FINDLAY M
Citation: Lp. Rivory et al., IRINOTECAN (CPT-11) - A PRELIMINARY INVESTIGATION OF THE RELATIONSHIPBETWEEN TROUGH CONCENTRATIONS OF THE ACTIVE METABOLITE, SN-38, AND TOXICITY, Annals of oncology, 9, 1998, pp. 222-222
Authors:
LAU YS
HAO RY
FUNG YK
FU LS
BISHOP JF
PFEIFFER RF
MOURADIAN MM
Citation: Ys. Lau et al., MODULATION OF NIGROSTRIATAL DOPAMINERGIC TRANSMISSION BY ANTISENSE OLIGODEOXYNUCLEOTIDE AGAINST BRAIN-DERIVED NEUROTROPHIC FACTOR, Neurochemical research, 23(4), 1998, pp. 525-532
Authors:
TONER GC
GREEN M
BISHOP JF
MCKENDRICK J
CEBON J
SHERIDAN WP
LOCKBAUM P
OBYRNE J
FOX RM
Citation: Gc. Toner et al., DOSE-ESCALATION STUDY OF CARBOPLATIN AND CYCLOPHOSPHAMIDE WITH FILGRASTIM SUPPORT - A PHASE-I STUDY, American journal of clinical oncology, 21(3), 1998, pp. 263-269
Authors:
CLAYTON MC
BISHOP JF
Citation: Mc. Clayton et Jf. Bishop, PERIOPERATIVE AND POSTOPERATIVE DRESSING TECHNIQUES FOR INTEGRA ARTIFICIAL SKIN - VIEWS FROM 2 MEDICAL-CENTERS, The Journal of burn care & rehabilitation, 19(4), 1998, pp. 358-363
Authors:
TEBBUTT N
RISCHIN D
QUINN M
ROME R
MILLWARD MJ
TONER GC
BISHOP JF
Citation: N. Tebbutt et al., A PHASE-II TRIAL OF CARBOPLATIN AND ETOPOSIDE FOR RELAPSED OR METASTATIC CARCINOMA OF THE CERVIX, Australian and New Zealand Journal of Obstetrics and Gynaecology, 38(1), 1998, pp. 87-90
Authors:
BISHOP JF
Citation: Jf. Bishop, APPROACHES TO INDUCTION THERAPY WITH ADULT ACUTE MYELOID-LEUKEMIA, Acta haematologica, 99(3), 1998, pp. 133-137
Authors:
MILLWARD MJ
ZALCBERG J
BISHOP JF
WEBSTER LK
ZIMET A
RISCHIN D
TONER GC
LAIRD J
COSOLO W
URCH M
BRUNO R
LORET C
JAMES R
BLANC C
Citation: Mj. Millward et al., PHASE-I TRIAL OF DOCETAXEL AND CISPLATIN IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 15(2), 1997, pp. 750-758
Authors:
JOSCHKO MA
WEBSTER LK
BISHOP JF
GROVES J
YUEN K
OLVER IN
NARAYAN KN
BALL DL
Citation: Ma. Joschko et al., RADIOENHANCEMENT BY CISPLATIN WITH ACCELERATED FRACTIONATED RADIOTHERAPY IN A HUMAN TUMOR XENOGRAFT, Cancer chemotherapy and pharmacology, 40(6), 1997, pp. 534-539
Authors:
MICHAEL M
TONER GC
OLVER IN
FENESSY A
BISHOP JF
Citation: M. Michael et al., PHASE-I DOSE INTENSIFICATION STUDY OF 2-WEEKLY EPIRUBICIN WITH GM-CSFIN ADVANCED CANCER, American journal of clinical oncology, 20(3), 1997, pp. 259-262
Authors:
PARNIS FX
OLVER IN
SANDEMAN T
BISHOP JF
LAIDLAW C
Citation: Fx. Parnis et al., A PHASE-II TRIAL OF CISPLATIN AND INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED BLADDER-CANCER, American journal of clinical oncology, 20(3), 1997, pp. 319-321
Authors:
BISHOP JF
JOSHI G
MUELLER GP
MOURADIAN MM
Citation: Jf. Bishop et al., LOCALIZATION OF PUTATIVE CALCIUM-RESPONSIVE REGIONS IN THE RAT BDNF, Molecular brain research, 50(1-2), 1997, pp. 154-164
Authors:
BISHOP JF
MACAROUNASKIRCHMAN K
Citation: Jf. Bishop et K. Macarounaskirchman, THE PHARMACOECONOMICS OF CANCER THERAPIES, Seminars in oncology, 24(6), 1997, pp. 106-111
Authors:
BISHOP JF
DEWAR J
TONER G
TATTERSALL MH
OLVER I
ACKLAND S
KENNEDY I
GOLDSTEIN D
GURNEY H
WALPOLE E
LEVI J
STEPHENSON J
Citation: Jf. Bishop et al., A RANDOMIZED STUDY OF PACLITAXEL VERSUS CYCLOPHOSPHAMIDE METHOTREXATE/5-FLUOROURACIL/PREDNISONE IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS/, Seminars in oncology, 24(5), 1997, pp. 5-9
Authors:
BISHOP JF
Citation: Jf. Bishop, THE TREATMENT OF ADULT ACUTE MYELOID-LEUKEMIA, Seminars in oncology, 24(1), 1997, pp. 57-69
Authors:
MICHAEL M
BISHOP JF
LEVI JA
BELL DR
ZALCBERG JR
FRIEDLANDER ML
OLVER IN
SMITH JG
TONER GC
Citation: M. Michael et al., AUSTRALIAN MULTICENTER PHASE-II TRIAL OF PACLITAXEL IN WOMEN WITH METASTATIC BREAST-CANCER AND PRIOR CHEMOTHERAPY, Medical journal of Australia, 166(10), 1997, pp. 520-523
Authors:
BISHOP JF
MATTHEWS JP
YOUNG GAR
BRADSTOCK K
Citation: Jf. Bishop et al., CLINICAL PREDICTORS OF RESISTANT LEUKEMIA AND INDUCTION DEATHS IN PATIENTS ON INTENSIVE INDUCTION CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 318-318
CREMOPHOR PHARMACOKINETICS IN PATIENTS RECEIVING 3-HOUR, 6-HOUR, AND 24-HOUR INFUSIONS OF PACLITAXEL
Authors:
RISCHIN D
WEBSTER LK
MILLWARD MJ
LINAHAN BM
TONER GC
WOOLLETT AM
MORTON CG
BISHOP JF
Citation: D. Rischin et al., CREMOPHOR PHARMACOKINETICS IN PATIENTS RECEIVING 3-HOUR, 6-HOUR, AND 24-HOUR INFUSIONS OF PACLITAXEL, Journal of the National Cancer Institute, 88(18), 1996, pp. 1297-1301
Authors:
RANSOM DT
LEONARD JH
KEARSLEY JH
TURBETT GR
HEEL K
SOSARS V
HAYWARD NK
BISHOP JF
Citation: Dt. Ransom et al., LOSS OF HETEROZYGOSITY STUDIES IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK, Head & neck, 18(3), 1996, pp. 248-253
Authors:
OLVER IN
HUGHES PG
SMITH JG
NARAYAN K
BISHOP JF
Citation: In. Olver et al., CONCURRENT RADIOTHERAPY AND CONTINUOUS AMBULATORY INFUSION 5-FLUOROURACIL IN ADVANCED HEAD AND NECK-CANCER, European journal of cancer, 32A(2), 1996, pp. 249-254
Authors:
BISHOP JF
Citation: Jf. Bishop, DOES IT MATTER HOW REMISSION IS ACHIEVED IN ACUTE-LEUKEMIA, Leukemia, 10, 1996, pp. 7-9
Authors:
WANG W
HAHN KH
BISHOP JF
GAO DQ
JOSE PA
MOURADIAN MM
Citation: W. Wang et al., UP-REGULATION OF D-3 DOPAMINE-RECEPTOR MESSENGER-RNA BY NEUROLEPTICS, Synapse, 23(3), 1996, pp. 232-235